Recordati Reports 7.5% Revenue Growth in First Nine Months
Recordati (RCDTF) has released its financial results for the first nine months of the year, reporting a net revenue of €2,103.7 million. This represents a 7.5% increase compared to the previous period. The company also reported earnings per share (EPS) of €1.950. These figures reflect steady top-line growth as the pharmaceutical firm continues its operational momentum through the third quarter.
